TELA BIO INC. - COMMON STOCK

TELA Bio Announces Publication of 24-Month BRAVO Study Results Demonstrating Benefits of OviTex® Reinforced Tissue Matrix in Hernia Repair

26 Oct 2022 07:00:00 By Nasdaq GlobeNewswire

TELA Bio to Participate in Upcoming Investor Conferences

01 Sep 2022 07:00:01 By Nasdaq GlobeNewswire

TELA Bio to Participate in Inaugural Gilmartin Group Emerging Growth Company Showcase

23 Aug 2022 16:01:00 By Nasdaq GlobeNewswire

TELA Bio Announces Closing of Public Offering of Common Stock and Full Exercise of Underwriter’s Option to Purchase Additional Shares

18 Aug 2022 16:01:00 By Nasdaq GlobeNewswire

TELA Bio Announces Pricing of Public Offering of Common Stock

15 Aug 2022 22:20:00 By Nasdaq GlobeNewswire

TELA Bio Announces Proposed Public Offering of Common Stock

15 Aug 2022 16:01:00 By Nasdaq GlobeNewswire

TELA Bio Reports Second Quarter 2022 Financial Results

10 Aug 2022 16:01:00 By Nasdaq GlobeNewswire

TELA Bio to Participate in Upcoming Investor Conferences

05 Aug 2022 07:00:00 By Nasdaq GlobeNewswire

TELA Bio Highlights Results from BRAVO and ReBAR Studies on the Benefits of OviTex® Reinforced Tissue Matrix in Hernia Repairs; Data to Be Presented at 2022 American Hernia Society (AHS) Meeting

04 Aug 2022 07:00:02 By Nasdaq GlobeNewswire

TELA Bio Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

29 Jul 2022 16:01:00 By Nasdaq GlobeNewswire

TELA Bio to Announce Second Quarter 2022 Financial Results

27 Jul 2022 07:00:00 By Nasdaq GlobeNewswire

TELA Bio Awarded Synthetic Bioabsorbable Mesh Products Agreement with Premier, Inc.

20 Jul 2022 07:00:00 By Nasdaq GlobeNewswire

TELA Bio to Participate in Upcoming JMP Securities Life Sciences Conference

02 Jun 2022 07:00:00 By Nasdaq GlobeNewswire

TELA Bio Secures Up to $50 Million in Debt Financing from MidCap Financial

31 May 2022 07:00:00 By Nasdaq GlobeNewswire

TELA Bio to Participate in Upcoming Jefferies Healthcare Conference

26 May 2022 07:00:00 By Nasdaq GlobeNewswire

TELA Bio Reports First Quarter 2022 Financial Results

10 May 2022 16:01:01 By Nasdaq GlobeNewswire

TELA Bio to Participate in Upcoming 2022 H.C. Wainwright Annual Global Investment Conference

09 May 2022 07:00:01 By Nasdaq GlobeNewswire

TELA Bio Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

29 Apr 2022 17:00:00 By Nasdaq GlobeNewswire

TELA Bio to Announce First Quarter 2022 Financial Results

26 Apr 2022 07:00:01 By Nasdaq GlobeNewswire

TELA Bio Appoints D. Taylor Ocasio as General Counsel

18 Apr 2022 07:00:00 By Nasdaq GlobeNewswire